Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CorMedix Inc CRMD

CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections... see more

Recent & Breaking News (NDAQ:CRMD)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving CorMedix, Inc. and a Lead Plaintiff Deadline of September 4, 2015 -- CRMD

GlobeNewswire August 12, 2015

CorMedix Inc. Announces Janet D. Dillione Will Join Board of Directors

Accesswire August 6, 2015

CorMedix Inc. Announces Janet D. Dillione Will Join Board of Directors

Accesswire August 6, 2015

CorMedix Inc. Announces Janet D. Dillione Will Join Board of Directors

Accesswire August 6, 2015

CorMedix Inc. Announces Janet D. Dillione Will Join Board of Directors

Accesswire August 6, 2015

SECURITIES ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against CorMedix, Inc. to Recover Investor Losses -- CRMD

GlobeNewswire July 31, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 4, 2015 - CRMD

PR Newswire July 31, 2015

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against CorMedix, Inc.

PR Newswire July 24, 2015

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in CorMedix, Inc. of Class Action Lawsuit and Upcoming Deadline - CRMD

GlobeNewswire July 24, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of CorMedix, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 4, 2015 -- CRMD

GlobeNewswire July 22, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of CorMedix, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 4, 2015 -- CRMD

GlobeNewswire July 22, 2015

CorMedix Inc. Announces Decision to Initiate Neutrolin Phase 3 Clinical Study

Accesswire July 17, 2015

CorMedix Inc. Announces Decision to Initiate Neutrolin Phase 3 Clinical Study

Accesswire July 17, 2015

TRADING ALERT: The Rosen Law Firm Reminds CorMedix, Inc. Investors of the Important Deadline in the Class Action

Business Wire July 17, 2015

CRMD INVESTOR ALERT: Investigation of CorMedix, Inc. Announced by The Law Offices of Howard G. Smith

Business Wire July 17, 2015

Robbins Arroyo LLP: CorMedix, Inc. (CRMD) Misled Shareholders According to a Recently Filed Class Action

PR Newswire July 13, 2015

Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against CorMedix, Inc. -- CRMD

GlobeNewswire July 10, 2015

Stull, Stull & Brody Announces Class Action Suit on Behalf of Purchasers of Common Shares of CorMedix, Inc. -- CRMD

GlobeNewswire July 9, 2015

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against CorMedix Inc.

PR Newswire July 8, 2015

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in CorMedix, Inc. to Contact the Firm

Marketwired July 8, 2015